STSze Man Tse

Sze Man Tse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sze Man Tse has a total of 207 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Combining label-free Raman spectroscopy with machine learning to monitor COVID-19 disease from acute infection to recovery

    by Frédéric Leblond, Frédérick Dallaire, Guillaume Sheehy, Hugo Soudeyns, Sze Man Tse, Caroline Quach, Daniel E. Kaufmann, Katherine Ember, Mathieu Dehaes

    SignificanceMonitoring COVID-19 disease from acute infection to recovery is critical to understand biochemical dysregulation and COVID-19 heterogeneity over time.AimOur aim is to develop an approach combining label-free Raman spectroscopy and machine learning modeling to enable sensitive biomolecular detection of COVID-19 over time.ApproachHospitalized patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were recruited and stratified based on respiratory support (critical and non-critical). Controls had a negative SARS-CoV-2 test. Blood was collected in the acute and recovery phases and was analyzed with Raman spectroscopy. Four machine learning models based on Raman spectra were developed to differentiate critical and non-critical patients in the acute and recovery phases from controls. For each group of patients, two additional models also classified the patient status (acute versus recovery) using cross-sectional and longitudinal analyses.ResultsRaman peaks assigned to proteins, glucose, fatty acids, lactic acid, vitamin A, and lipids were identified in models. Overall, area under the receiver operating characteristic curve values were between 0.83 and 1.00 with sensitivities, specificities, and accuracies between 73% and 100%, 77% and 100%, and 78% and 100%, respectively.ConclusionsThese results highlight the capability of combined Raman spectroscopy and machine learning modeling to stratify patients at admission, monitor recovery after discharge, and support strategies to potentially reduce the risk of long-COVID.

  • Open Access

    2025 Canadian Pediatric Severe Asthma Stakeholders’ Forum proceedings

    by Sze Man Tse, Sharon D. Dell, Larry C. Lands, Anne Hicks, Andréanne Côté, Cristina Longo, Dhenuka Radhakrishnan, Simon Rousseau, Padmaja Subbarao, Connie Yang, et al.

    Asthma affects approximately 13% of Canadian children.1 Severe asthma, whose control requires high-dose inhaled corticosteroids (ICS) and a second controller medication or daily systemic corticoste...

  • Open Access

    Understanding inhaler users’ perceptions of climate change and inhaler carbon footprints: insights from a Canadian survey

    by Stacey J Butler, Geneviève C Digby, Caitlin Roy, Sze Man Tse, Shellyza Sajwani, Jill Hubick, Carolyn McCoy, Ivy Lam, Alexander Singer, Alan Kaplan, et al.

    Background: People with lung diseases are vulnerable to climate change, yet metered dose inhalers (MDIs) have significant climate impacts. We sought to understand inhaler users’ perspectives on climate change and awareness of inhaler climate implications. Methods: Canadians (aged ≥16 years) who reported using an inhaler in the previous 6 months were invited via health organisations’ newsletters to complete an online survey (November 2024–March 2025). Multivariate regression models assessed the association between sociodemographic factors and climate change risk perception, disposal practices and awareness of inhaler climate implications. Results: There were 343 respondents (median age 71 years (IQR: 64–76 years), 65% female, 80% MDI users). Individuals were concerned (45%) or very concerned (39%) about climate change, but only 20% were previously aware of inhaler climate implications. Advancing age (OR 0.58, 95% CI 0.45 to 0.74) was associated with being unaware of inhaler climate implications, while a university education (OR 4.86, 95% CI 1.77 to 16.62) and living in a large urban area (OR 2.81, 95% CI 1.21 to 7.45) were associated with greater awareness. Most respondents reported disposing of their inhalers in garbage or recycling bins (70%) and provincial pharmacy return programmes were underused (27%) when available. Nearly all MDI users (92%) were willing to switch to a lower carbon footprint device. Advice from healthcare providers was valued in supporting treatment decisions. Interpretation: Inhaler users are concerned about climate change but lack awareness of inhaler climate impacts. Sustainability interventions that promote education, safe use of low carbon devices and recycling could reduce inhaler-related climate impacts.


  • Open Access

    Combining label-free Raman spectroscopy and machine learning to identify early biomarkers of COVID-19 disease severity and mortality

    by Maryam Heidarifard, Katherine Ember, Frédérick Dallaire, Elsa Brunet-Ratnasingham, Yiheng Chen, Nassim Ksantini, Myriam Mahfoud, Guillaume Sheehy, Hugo Soudeyns, Philippe Jouvet, et al.

    Early prediction of COVID-19 severity and mortality is crucial for optimizing clinical care and patient outcomes, but remains challenging. We aim to develop a screening tool combining label-free Raman spectroscopy and machine learning modeling to predict COVID-19 severity and mortality. Patients infected by SARS-CoV-2 (N=58) were recruited during the first wave of COVID-19 and stratified based on respiratory support. Blood samples were collected during hospitalization and analyzed using Raman spectroscopy and metabolomics. Machine learning models based on Raman spectra were developed to classify (1) survivors versus nonsurvivors, (2) critical patients with noninvasive versus invasive ventilation, and (3) noncritical (no respiratory support or oxygen via nasal cannula) versus critical patients. Raman peaks assigned to proteins, glucose, lactic acid, fatty acids, urea, and lipids were extracted by the models. Area under the receiver operating characteristic curve ranged between 0.83 and 0.94, with sensitivities and specificities ranging between 80% and 83% and 75% and 92%, respectively. Accuracy for detecting mortality, invasive ventilation, and critical disease was 90%, 87%, and 78%. A complementary metabolomic analysis confirmed some molecular differences between groups. These results suggest the potential of Raman spectroscopy and machine learning modeling to stratify COVID-19 patients at admission, individualize care, and improve survival rates.


  • Open Access

    Using mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study

    by Naphtal Nyirimanzi, Myriam Bransi, François-Pierre Counil, Olivier Drouin, Jocelyn Gravel, Anne Hicks, Cristina Longo, Theo J Moraes, Esli Osmanlliu, Dhenuka Radhakrishnan, et al.

    Background: Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. Objective: The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. Methods: This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. Results: We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. Conclusions: The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.


  • Open Access

    Using mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study (Preprint)

    by Naphtal Nyirimanzi, Myriam Bransi, François-Pierre Counil, Olivier Drouin, Jocelyn Gravel, Anne Hicks, Cristina Longo, Theo J Moraes, Esli Osmanlliu, Dhenuka Radhakrishnan, et al.

    BACKGROUND Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. OBJECTIVE The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. METHODS This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. RESULTS We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. CONCLUSIONS The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.

  • Open Access

    Higher temperatures are associated with increased asthma-related emergency department visits among children: a time series analysis of environmental exposures in Montreal, Canada

    by Sze Man Tse, Sadio Sambahke, Masoumeh Sajedi, Jocelyn Gravel, Esli Osmanlliu

    Asthma exacerbations are a leading cause of emergency department (ED) visits in children. Outdoor exposures such as air pollutants and meteorological factors have been associated with risk of asthma exacerbations. We evaluated the association between ambient temperature, relative humidity, and air quality on pediatric asthma-related ED visits in Montréal, Canada. In this retrospective study, we included children ≤ 17 years presenting with asthma to two pediatric EDs between January 1, 2017 and December 31st, 2020. Temperature and relative humidity data were obtained daily for Montréal through Weather Source™ and the Air Quality Health Index (AQHI) through Environment Canada. We evaluated the association between environmental exposures and the incidence of asthma-related ED visits using a quasi-Poisson regression analysis, adjusting for seasonality. We examined 21 201 asthma-related ED visits. Increased temperature was associated with an increased number of asthma-related ED visits. Compared to the reference decile (2.8 to 7.5⁰C), the strongest association with incident ED visits was for a temperature of 15.8 to 19.3⁰C, associated with a 37% increase in the number of asthma-related ED visits (IRR = 1.37, 95% CI 1.22, 1.54). Current day relative humidity, AQHI, and changes of the exposure levels over the previous 1 to 7 days did not have an effect on asthma-related ED visits. Adjusting for seasonality, higher temperatures were associated with an increased number of asthma-related ED visits among children while humidity and air quality were not. At a population level, this can inform hospitals of upcoming trends in ED visits.